Based on current projections, up to 50 million COVID-19 vaccine doses will be distributed globally in 2020 and up to 1.3 billion doses by the end of 2021. Some vaccines in development must maintain a consistent temperature of approximately -70°C ±10°C (94°F ±14°F) during storage and shipment to remain stable and viable, which presents a logistical challenge in the global distribution. This is where Cold Jet® is making a difference.
Cold Jet – the worldwide leader in the manufacturing of dry ice production and blasting equipment – is helping industry and governments to safely distribute billions of COVID-19 vaccine doses around the world.
